Search Results - "Fieschi, Cesare"

Refine Results
  1. 1
  2. 2

    Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial by Bogousslavsky, Julien, Victor, Stephen J, Salinas, Eliseo O, Pallay, Allan, Donnan, Geoffrey A, Fieschi, Cesare, Kaste, Markku, Orgogozo, Jean-Marc M, Chamorro, Angel, Desmet, Anne

    “…Trafermin (basic fibroblast growth factor) has been shown to reduce infarct volume in acute ischemic stroke models, and to promote functional recovery and new…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Morphological and functional characteristics of patent foramen ovale and their embolic implications by DE CASTRO, Stefano, CARTONI, Domenico, PANDIAN, Natesa G, FIORELLI, Marco, RASURA, Maurizia, ANZINI, Alexia, ZANETTE, Elietta M, BECCIA, Mario, COLONNESE, Claudio, FEDELE, Francesco, FIESCHI, Cesare

    Published in Stroke (1970) (01-10-2000)
    “…Transesophageal echocardiography (TEE) has detected a high prevalence of patent foramen ovale (PFO) in stroke patients, but the clinical implications of the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Thrombolysis in acute ischemic stroke: controlled trials and clinical experience by Hacke, W, Brott, T, Caplan, L, Meier, D, Fieschi, C, von Kummer, R, Donnan, G, Heiss, W D, Wahlgren, N G, Spranger, M, Boysen, G, Marler, J R

    Published in Neurology (1999)
    “…Thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) is approved in the United States for treatment of acute ischemic stroke. Approval was…”
    Get full text
    Journal Article
  11. 11

    Motor stimulation response by technetium-99m hexamethylpropylene amine oxime split-dose method and single photon emission tomography by Pantano, P, Di Piero, V, Ricci, M, Fieschi, C, Bozzao, L, Lenzi, G L

    Published in European Journal of Nuclear Medicine (01-11-1992)
    “…We applied the technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) split-dose method in order to evaluate the feasibility of assessing cerebral blood…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Long-term prognosis after a minor stroke : 10-year mortality and major stroke recurrence rates in a hospital-based cohort by PRENCIPE, M, CULASSO, F, RASURA, M, ANZINI, A, BECCIA, M, CAO, M, GIUBILEI, F, FIESCHI, C

    Published in Stroke (1970) (1998)
    “…Determinants of long-term outcome are not well defined in minor stroke patients. This study aims to evaluate which factors are independent long-term predictors…”
    Get full text
    Conference Proceeding Journal Article
  16. 16

    Prevention of Venous Thromboembolism after Acute Ischemic Stroke with Enoxaparin Versus Unfractionated Heparin and the Impact of Stroke Severity by Sherman, David G., Albers, Gregory W., Bladin, Christopher, Chen, Min, Fieschi, Cesare, Gabbai, Alberto A., Kase, Carlos S., O'Riordan, William, Pineo, Graham F.

    Published in Blood (16-11-2006)
    “…Background: Venous thromboembolism (VTE) prophylaxis with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) is recommended in acute ischemic…”
    Get full text
    Journal Article
  17. 17

    Corticotropin-releasing factor : effect on cerebral blood flow in physiologic and ischaemic conditions by DE MICHELE, Manuela, TOUZANI, Omar, FOSTER, Alan C, FIESCHI, Cesare, SETTE, Giuliano, MCCULLOCH, James

    Published in Experimental brain research (01-09-2005)
    “…The expression of corticotrophin-releasing factor (CRF) receptors in cerebral arteries and arterioles suggests that CRF may modulate cerebral blood flow (CBF)…”
    Get full text
    Journal Article
  18. 18

    Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours by Fieschi, C, Argentino, C, Lenzi, G L, Sacchetti, M L, Toni, D, Bozzao, L

    Published in Journal of the neurological sciences (01-07-1989)
    “…The development of fibrinolytic agents such as streptokinase and recombinant tissue type plasminogen activator (r-TPA) and other modalities of treatment in…”
    Get more information
    Journal Article
  19. 19
  20. 20